Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Leiomyoma 3

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × asoprisnil × Clear all
NCT00156182 2009-03-04

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Abbott

Phase 2 Completed
38 enrolled

Leiomyoma

NCT00150644 2008-05-29

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Abbott

Phase 2 Completed
33 enrolled

Leiomyoma

NCT00160459 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Abbott

Phase 2 Completed
129 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡